Spotlight on Aggressive Non-Hodgkin Lymphomas (NHL)
June 7, 2023
Join us for a free webinar covering the latest information for patients and caregivers.
To register by phone, call (855) 314-6950.
We invite you to learn more about:
- Treatment options for aggressive subtypes of non-Hodgkin lymphoma (NHL)
- CAR T-cell therapy for aggressive lymphomas
- Side-effects management
- Questions to ask your healthcare team about treatment options and quality of life issues
Jason Westin, MD, MS, FACP
Director, Lymphoma Clinical Research
Section Chief, Aggressive Lymphoma
Department of Lymphoma & Myeloma
The University of Texas at MD Anderson Cancer Center
Submit a question for Dr. Westin to answer during the Q&A session.
Support for this program is provided by Bristol Myers Squibb, Eli Lilly and Company, Genmab US & AbbVie Inc., Incyte Corporation, Kite, A Gilead Company, Merck & Company, and MorphoSys US.